24.32
-0.18
(-0.73%)
As of 12:50:23 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 4 | 2 | 1 |
| Avg. Estimate | -0.18 | -0.01 | -0.54 | 2.74 |
| Low Estimate | -0.4 | -0.19 | -0.71 | 2.74 |
| High Estimate | 0.04 | 0.13 | -0.37 | 2.74 |
| Year Ago EPS | 0.36 | 0.07 | -0.02 | -0.54 |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 6 | 6 |
| Avg. Estimate | 68.87M | 68.47M | 268.03M | 292.65M |
| Low Estimate | 59M | 64.75M | 232M | 265.84M |
| High Estimate | 79.7M | 76.1M | 292.88M | 360.12M |
| Year Ago Sales | 62.43M | 77.87M | 275.65M | 268.03M |
| Sales Growth (year/est) | 10.31% | -12.07% | -2.76% | 9.19% |
Earnings History
| Currency in EUR | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.13 | -0.02 | -0.12 | -0.3 |
| EPS Actual | 0.36 | 0.07 | -0.74 | 0.29 |
| Difference | 0.49 | 0.09 | -0.62 | 0.59 |
| Surprise % | 376.92% | 450.00% | -504.08% | 195.10% |
EPS Trend
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.18 | -0.01 | -0.54 | 2.74 |
| 7 Days Ago | -0.09 | 0.03 | -0.44 | 1.7 |
| 30 Days Ago | -0.09 | 0.03 | -0.65 | -0.67 |
| 60 Days Ago | -0.17 | -0.17 | -0.81 | -0.87 |
| 90 Days Ago | -0.17 | -0.17 | -0.81 | -0.87 |
EPS Revisions
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 2 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GLPG | -150.00% | -117.86% | -2,683.51% | 607.41% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Downgrade | Morgan Stanley: Equal-Weight to Underweight | 2/14/2025 |
| Downgrade | Barclays: Equal-Weight to Underweight | 1/23/2025 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 11/1/2024 |
| Initiated | Leerink Partners: Market Perform | 9/9/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/22/2024 |
| Downgrade | B of A Securities: Neutral to Underperform | 4/1/2024 |
Related Tickers
REPL Replimune Group, Inc.
7.97
-7.51%
KURA Kura Oncology, Inc.
6.16
-5.59%
SPRO Spero Therapeutics, Inc.
0.6562
-7.05%
ASMB Assembly Biosciences, Inc.
9.26
-2.27%
STOK Stoke Therapeutics, Inc.
6.28
-4.85%
PHVS Pharvaris N.V.
15.11
+1.07%
PTCT PTC Therapeutics, Inc.
46.75
-3.35%
ASND Ascendis Pharma A/S
153.66
+1.00%
PRQR ProQR Therapeutics N.V.
1.3300
-2.93%
KROS Keros Therapeutics, Inc.
9.99
-0.50%